GlyChrome

by DC · capsule · 60 capsules

  • On the market (NIH)
  • UPC 0 52301 30160 7
  • DSLD label 266652
  • Serving 1 capsule
  • 60 servings

GlyChrome by DC lists one ingredient: 400 mcg of chromium per serving of 1 capsule. Its current label entered the NIH Dietary Supplement Label Database on February 23, 2022.

What is in GlyChrome?

Each row as the label prints it, per serving of 1 capsule. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

GlyChrome: Supplement Facts rows against the market (DSLD label 266652, January 2026 release)
IngredientAmount% DVAmong products listing it
Chromiumas Chromium Dinicocysteinate400 mcg333%Chromium in GlyChrome against 7,825 products400 mcg per serving; the middle half of products list 45 mcg to 200 mcg, the median 100 mcg.DV 35 mcg400 mcg

Higher than 93% of 7,825 products listing chromium (median 100 mcg).

Source: NIH ODS Dietary Supplement Label Database, label 266652 (entered February 23, 2022), version 9.4.0. See the label on DSLD or its label image (PDF). Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

The rows in the top or bottom tenth of the products that list the same ingredient, and any above the adult upper limit at the most servings a day the directions give:

  • Its 400 mcg of chromium is higher than 93% of the 7,825 chromium products that print an amount; 391 list more.

The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

6 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Warnings
Tamper Evident: Do not use this product if imprinted foil seal under cap is broken or missing.
Keep out of reach of children.
Warning: Diabetics/Hypoglycemics use only under a doctor's supervision because this product contains chromium which may enhance insulin sensitivity and may affect your blood sugar.
If you are pregnant or nursing do not take this product.
Allergens and what it does not contain
Gluten free
Storage
Directions: As a dietary supplement, take 1 capsule daily, preferably with a meal.
Keep tightly closed. Store at room temperature: 59 degrees - 86 degrees F (15 degrees to 30 degrees C).

Source: label statements in DSLD label 266652.

What else is on the label?

Other ingredients: Cellulose, Gelatin, Silica, Magnesium Stearate.

Seals and symbols as the label prints them (the maker's; a certifier's own list confirms a seal): Quali Pure.

How many labels does GlyChrome have?

One label is on file, entered on February 23, 2022.

  1. Label 266652 (current) Entered February 23, 2022 · on the market · 60 capsules · UPC 0 52301 30160 7

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Dee Cee Laboratories, Inc. (manufacturer), White House, TN. All DC products.

Where next?